Nisha Nanda
Directeur/Bestuurslid bij MORPHIC HOLDING, INC.
Vermogen: - $ op 31-05-2024
Actieve functies van Nisha Nanda
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MORPHIC HOLDING, INC. | Directeur/Bestuurslid | 19-08-2021 | - |
| Independent Dir/Board Member | 19-08-2021 | - |
Loopbaan van Nisha Nanda
Eerdere bekende functies van Nisha Nanda
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| LOXO ONCOLOGY INC | Corporate Officer/Principal | 01-02-2014 | 01-05-2023 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01-02-2012 | 01-02-2014 |
Opleiding van Nisha Nanda
| The University of New South Wales | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Australië | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MORPHIC HOLDING, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Beurs
- Insiders
- Nisha Nanda
- Ervaring
